MedTrace Logo

Genetics of Mendelian Diseases in Qatar

NCT02021734 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2025-11-17

No results posted yet for this study

Summary

There are certain categories of diseases which are more prevalent in the Arab world due to increased rates of consanguinity in relatively isolated populations. The goal is to discover these mutations by using next-generation human genetics tools.

Conditions

  • Mendelian Disorders

Sponsors & Collaborators

  • Hamad Medical Corporation

    collaborator INDUSTRY

  • Weill Cornell Medical College in Qatar

    collaborator OTHER

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Ronald Crystal, MD · Weill Medical College of Cornell University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-11-19
Primary Completion
2022-06-30
Completion
2025-02-28

Countries

  • Qatar

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02021734 on ClinicalTrials.gov